Boundless Bio, Inc. (BOLD) vs InterCure Ltd. (INCR)
A side-by-side comparison of Boundless Bio, Inc. and InterCure Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BOLD
Boundless Bio, Inc.
$2.57HealthcareDelayed quote: Oct 6, 2026, 11:41 AM EDT
INCR
InterCure Ltd.
$5.50HealthcareDelayed quote: Oct 6, 2026, 11:44 AM EDT
Total return — BOLD vs INCR
growth of $100 · dividends reinvested · last 3yBOLD -81.8% (-43.3%/yr)INCR -56.9% (-24.5%/yr)INCR compounded faster over this window
BOLD INCR
BOLD vs INCR: by the numbers
- •INCR is the larger company ($65M vs $58M market cap).
- •Both run net losses; BOLD's is the smaller (0.00% vs -13.72% net margin).
Metrics side by side
Valuation
| Metric | BOLD | INCR |
|---|---|---|
| P/S ratio | N/A | 0.82 |
| P/B ratio | 0.88 | 0.52 |
| FCF yield | N/A | 11.28% |
Profitability
| Metric | BOLD | INCR |
|---|---|---|
| Gross margin | 0.00% | 14.40% |
| Operating margin | 0.00% | 2.49% |
| Net margin | 0.00% | -13.72% |
| ROE | -58.99% | -8.80% |
| ROIC | -43.97% | -4.72% |
Growth (annualized)
| Metric | BOLD | INCR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 32.71% |
| Total return CAGR (5Y) | N/A | -30.85% |
Go deeper
Dig into the metrics
Boundless Bio ROEInterCure ROEBoundless Bio operating marginInterCure operating marginBoundless Bio revenue growthInterCure revenue growthBoundless Bio free cash flowInterCure free cash flow
Boundless Bio & InterCure appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.